HIV vaccine research--South Africa's ethical-legal framework and its ability to promote the welfare of trial participants.
An effective ethical-legal framework for the conduct of research is critical. We describe five essential components of such a system, review the extent to which these components have been realised in South Africa, present brief implications for the ethical conduct of clinical trials of HIV vaccines in South Africa and make recommendations. The components of an effective ethical-legal system that we propose are the existence of scientific ethical and policy-making structures that regulate research; research ethics committees (RECs) that ethically review research; national ethical guidelines and standards; laws protecting research participants; and mechanisms to enforce and monitor legal rights and ethical standards. We conclude that the ethical-legal framework has, for the most part, the necessary institutions, and certain necessary guidelines but does not have many of the laws needed to protect and promote the rights of persons participating in research, including HIV vaccine trials. Recommendations made include advocacy measures to finalise and implement legislation, development of regulations, analysis and comparison of ethical guidelines, and the development of measures to monitor ethical-legal rights at trial sites.
Strode
Ann
A
Faculty of Law, Pietermaritzburg centre, University of KwaZulu-Natal. strodea@ukzn.ac.za
Slack
Catherine
C
Mushariwa
Muriel
M
D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000191:economics*; D017321:Clinical Trials, Phase I as Topic; D003906:Developing Countries; D032984:Ethics, Research; D005260:Female; D015658:HIV Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D018579:Patient Selection / Q000941:ethics; D018570:Risk Assessment; D012946:Social Welfare / Q000191:economics*; D012959:Socioeconomic Factors; D013019:South Africa
D016915:AIDS Vaccines